RU2334738C2 - Кристаллические формы - Google Patents

Кристаллические формы Download PDF

Info

Publication number
RU2334738C2
RU2334738C2 RU2004106528/04A RU2004106528A RU2334738C2 RU 2334738 C2 RU2334738 C2 RU 2334738C2 RU 2004106528/04 A RU2004106528/04 A RU 2004106528/04A RU 2004106528 A RU2004106528 A RU 2004106528A RU 2334738 C2 RU2334738 C2 RU 2334738C2
Authority
RU
Russia
Prior art keywords
strong
peak intensity
good
characteristic
weak
Prior art date
Application number
RU2004106528/04A
Other languages
English (en)
Russian (ru)
Other versions
RU2004106528A (ru
Inventor
Паул Адриан ВАН-ДЕР-САФ (CH)
Паул Адриан ВАН-ДЕР-САФ
Клаудиа МАРКОЛЛИ (CH)
Клаудиа МАРКОЛЛИ
Мартин ШЕЛАГЕВИЧ (CH)
Мартин ШЕЛАГЕВИЧ
Андреас БУРКХАРД (CH)
Андреас Буркхард
Хайнц ВОЛЛЕБ (CH)
Хайнц ВОЛЛЕБ
Аннемари ВОЛЛЕБ (CH)
Аннемария ВОЛЛЕБ
Original Assignee
Циба Спешиалти Кемикэлз Холдинг Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Циба Спешиалти Кемикэлз Холдинг Инк. filed Critical Циба Спешиалти Кемикэлз Холдинг Инк.
Publication of RU2004106528A publication Critical patent/RU2004106528A/ru
Application granted granted Critical
Publication of RU2334738C2 publication Critical patent/RU2334738C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
    • C07F1/04—Sodium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
RU2004106528/04A 2001-08-03 2002-07-25 Кристаллические формы RU2334738C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01810756 2001-08-03
EP01810756.5 2001-08-03

Publications (2)

Publication Number Publication Date
RU2004106528A RU2004106528A (ru) 2005-07-27
RU2334738C2 true RU2334738C2 (ru) 2008-09-27

Family

ID=8184071

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004106528/04A RU2334738C2 (ru) 2001-08-03 2002-07-25 Кристаллические формы

Country Status (16)

Country Link
US (1) US6696479B2 (enExample)
EP (1) EP1429757B8 (enExample)
JP (2) JP4681808B2 (enExample)
KR (1) KR100975782B1 (enExample)
CN (2) CN1536999B (enExample)
AR (1) AR036205A1 (enExample)
AT (1) ATE391502T1 (enExample)
AU (1) AU2002333271B2 (enExample)
CA (1) CA2454072A1 (enExample)
DE (1) DE60226044T2 (enExample)
ES (1) ES2304140T3 (enExample)
HU (1) HUP0401141A3 (enExample)
IL (2) IL159861A0 (enExample)
PL (1) PL366905A1 (enExample)
RU (1) RU2334738C2 (enExample)
WO (1) WO2003013512A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087631B2 (en) * 2002-07-18 2006-08-08 Inotek Pharmaceuticals Corporation Aryltetrazole compounds, and compositions thereof
CA2492949A1 (en) * 2002-07-26 2004-02-12 Ciba Specialty Chemicals Holding Inc. Crystalline polymorphic and amorphous forms of benazepril hydrochloride
WO2004096765A2 (en) * 2003-05-01 2004-11-11 Morepen Laboratories Ltd. A novel crystalline polymorph of fluvastatin sodium and a process for preparing it
US7368581B2 (en) 2003-06-18 2008-05-06 Teva Pharmaceutical Industries Ltd. Process for the preparation of fluvastatin sodium crystal from XIV
CA2610635A1 (en) * 2003-06-18 2004-12-29 Teva Pharmaceutical Industries Ltd Fluvastatin sodium crystal form lxxxvii, processes for preparing, compositions and methods of using
US7368468B2 (en) 2003-06-18 2008-05-06 Teva Pharmaceutical Industries Ltd. Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them
WO2005037424A1 (en) * 2003-10-06 2005-04-28 Solvias Ag Process for the parallel detection of crystalline forms of molecular solids
WO2005037787A1 (en) * 2003-10-16 2005-04-28 Ciba Specialty Chemicals Holding Inc. Crystalline form of fluvastatin sodium
US20070179166A1 (en) * 2003-12-24 2007-08-02 Valerie Niddam-Hildesheim Process for preparation of statins with high syn to anti ratio
US7851624B2 (en) * 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
WO2005080332A1 (en) * 2004-01-14 2005-09-01 Cadila Healthcare Limited Novel form of fluvastatin sodium
EP1711493A2 (en) * 2004-02-06 2006-10-18 CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement Crystalline forms of zolmitriptan
US7241800B2 (en) 2004-03-17 2007-07-10 Mai De Ltd. Anhydrous amorphous form of fluvastatin sodium
WO2006021967A1 (en) * 2004-08-26 2006-03-02 Biocon Limited Process for the preparation of fluvastatin sodium form a.
WO2006030304A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Novel forms of fluvastatin sodium, processes for preparation and pharmaceutical compositions thereof
US7795451B2 (en) * 2005-02-11 2010-09-14 Jubilant Organosys Limited Polymorphic forms of fluvastatin sodium and process for preparing the same
WO2006109147A1 (en) * 2005-04-12 2006-10-19 Glenmark Pharmaceuticals Limited Substantially pure amorphous fluvastatin, processes for its preparation and pharmaceutical compositions containing same
WO2007039784A2 (en) * 2005-10-06 2007-04-12 Wockhardt Limited A novel crystalline polymorph of fluvastatin sodium and process for preparing it
EP1948637A4 (en) * 2005-11-14 2010-09-08 Hetero Drugs Ltd PROCESS FOR AMORPHES ESOMEPRAZOLE
TW200804279A (en) * 2006-02-27 2008-01-16 Teva Pharma Fluvastatin sodium novel forms and preparation thereof
US20110015247A1 (en) * 2008-04-04 2011-01-20 Shodhana Laboratories Limited Novel crystalline form of carvedilol dihydrogen phosphate and related processes
CN101684121B (zh) * 2008-09-22 2013-04-03 重庆医药工业研究院有限责任公司 培美曲塞二酸的新晶型及其制备方法
JP6115288B2 (ja) * 2012-04-27 2017-04-19 株式会社島津製作所 質量分析におけるピーク検出方法及びそのシステム
TW201806928A (zh) * 2016-07-01 2018-03-01 第一三共股份有限公司 胺基羧酸之酸加成鹽的結晶及其製造方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
RU2121835C1 (ru) * 1991-12-12 1998-11-20 Новартис Аг Фармацевтическая композиция

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH23486A (en) * 1982-11-22 1989-08-16 Sanzoz Inc Indole analogs of mevalonolactone,pharmaceutical compositions containing the same and method of use thereof
WO1984002131A1 (fr) * 1982-11-22 1984-06-07 Sandoz Ag Produits analogues de mevalolactone et leurs derives, leurs procedes de production, compositions pharmaceutiques les contenant ainsi que leur utilisation en tant que produits pharmaceutiques
HRP960313B1 (en) * 1995-07-17 2002-08-31 Warner Lambert Co Form iii crystalline (r- (r*, r*)-2- (4-fluorophenyl) -beta-delta-hydroxy-5-(1-methylethyl) -3-phenyl-4- ((phenylamino) carbonyl -1h-pyrrole-1-heptanoic acid calcium salt (2:1)
EP0907639B1 (en) * 1996-06-24 2003-03-12 Novartis AG Polymorphic compounds
US6858643B2 (en) * 2000-10-31 2005-02-22 Ciba Specialty Chemicals Corporation Crystalline forms of Fluvastatin sodium

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
RU2121835C1 (ru) * 1991-12-12 1998-11-20 Новартис Аг Фармацевтическая композиция
EP0547000B1 (en) * 1991-12-12 2000-02-02 Novartis AG Stabilized pharmaceutical compositions comprising an HMG-CoA reductase inhibitor compound

Also Published As

Publication number Publication date
CA2454072A1 (en) 2003-02-20
HUP0401141A3 (en) 2011-07-28
AU2002333271B2 (en) 2007-08-09
JP2010265308A (ja) 2010-11-25
KR100975782B1 (ko) 2010-08-17
EP1429757A2 (en) 2004-06-23
KR20040022226A (ko) 2004-03-11
IL159861A (en) 2009-02-11
JP2005501838A (ja) 2005-01-20
WO2003013512A3 (en) 2003-11-20
CN1536999A (zh) 2004-10-13
EP1429757B1 (en) 2008-04-09
EP1429757B8 (en) 2008-07-16
CN102516150A (zh) 2012-06-27
US20030032666A1 (en) 2003-02-13
JP4681808B2 (ja) 2011-05-11
DE60226044T2 (de) 2009-05-14
PL366905A1 (en) 2005-02-07
WO2003013512A2 (en) 2003-02-20
CN1536999B (zh) 2012-08-08
ES2304140T3 (es) 2008-09-16
RU2004106528A (ru) 2005-07-27
DE60226044D1 (de) 2008-05-21
ATE391502T1 (de) 2008-04-15
AR036205A1 (es) 2004-08-18
US6696479B2 (en) 2004-02-24
HUP0401141A2 (hu) 2004-09-28
IL159861A0 (en) 2004-06-20

Similar Documents

Publication Publication Date Title
RU2334738C2 (ru) Кристаллические формы
US6858643B2 (en) Crystalline forms of Fluvastatin sodium
AU2002333271A1 (en) Crystalline forms of fluvastatin sodium
AU2002223639A1 (en) Crystalline forms of fluvastatin sodium
WO2002050036A1 (en) Crystalline forms of cerivastatin sodium
NZ531993A (en) New anhydrous crystalline forms of gabapentin
EP1942886A1 (en) New crystalline form of perindopril erbumine
WO2006030304A2 (en) Novel forms of fluvastatin sodium, processes for preparation and pharmaceutical compositions thereof
JP3637019B2 (ja) 新規な結晶性パミドロン酸二ナトリウム水和物及びその製造方法
Barger et al. XXX.—The alkaloids of ergot. Part II
SU1724580A1 (ru) Способ получени тетратиоарсената натри
JP2974862B2 (ja) 新規１―チア―４，６―ジアザスピロ〔４．４〕ノナン誘導体およびその製法
WO1996029308A1 (en) Anhydrous crystals
JPH068266B2 (ja) Ｌ−グルタミン酸マグネシウム五水和物結晶及びその製造法
AU2002330220A1 (en) New anhydrous crystalline forms of gabapentin
TH25623A (th) กรรมวิธีเพื่อการเตรียมลอราคาร์เบฟ โมโนไฮโดรต
JPS62289571A (ja) 含酸素複素環を有するアクリル酸誘導体及び製造方法

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20130726